Cargando…

Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation

Tanshinone IIA (Tan IIA) possesses potent anti-atherogenic function, however, the underlying pharmacological mechanism remains incompletely understood. Previous studies suggest that oxidized LDL (oxLDL)-induced NLRP3 (NOD-like receptor (NLR) family, pyrin domain-containing protein 3) inflammasome ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Jiexia, Chang, Yumei, Huo, Shanshan, Li, Wenyan, Huang, Heling, Gao, Yunhuan, Lin, Hongyu, Zhang, Jianlou, Zhang, Yonghong, Zuo, Yuzhu, Cao, Xuebin, Zhong, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835056/ https://www.ncbi.nlm.nih.gov/pubmed/33290264 http://dx.doi.org/10.18632/aging.202202

Ejemplares similares

NLRP3 inflammasome activation contributes to Listeria monocytogenes-induced animal pregnancy failure
por: Li, Wenyan, et al.
Publicado: (2016)

Tanshinone IIA Improves Acute Gouty Arthritis in Rats through Regulating Neutrophil Activation and the NLRP3 Inflammasome
por: Xu, Lianjie, et al.
Publicado: (2022)

Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis
por: Chen, Zhuo, et al.
Publicado: (2014)

Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages
por: Wang, Jiarou, et al.
Publicado: (2023)

Tanshinone IIA ameliorates myocardial ischemia/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation
por: Li, Dan, et al.
Publicado: (2022)

TanshinoneIIA inhibits melanocyte pyroptosis by regulating the ROS/NLRP3 signaling axis
por: Li, Xiaosha, et al.
Publicado: (2023)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)

Characterization and Stability of Tanshinone IIA Solid Dispersions with Hydroxyapatite
por: Wang, Xiaopan, et al.
Publicado: (2013)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats
por: Yan, Jun, et al.
Publicado: (2016)

Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
por: Zhai, Xifeng, et al.
Publicado: (2017)

Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
por: Zhao, Jia, et al.
Publicado: (2023)

Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia
por: Zhong, Liren, et al.
Publicado: (2020)

Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats
por: HE, HUANYU, et al.
Publicado: (2015)

Renoprotective Effects of Tanshinone IIA: A Literature Review
por: Chen, Zhengtao, et al.
Publicado: (2023)

Metabolism of Tanshinone IIA, Cryptotanshinone and Tanshinone I from Radix Salvia Miltiorrhiza in Zebrafish
por: Wei, Yingjie, et al.
Publicado: (2012)

Preparation of North American Type II PRRSV Infectious Clone Expressing Green Fluorescent Protein
por: Wang, Liyue, et al.
Publicado: (2014)

Corrigendum to “Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia”
por: Zhong, Liren, et al.
Publicado: (2020)

Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine
por: Cui, Dan, et al.
Publicado: (2018)

Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells
por: Zhao, Zhewei, et al.
Publicado: (2021)

Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)

Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
por: Jin, Ying, et al.
Publicado: (2019)

Tanshinone IIA Sodium Sulfonate Attenuates LPS-Induced Intestinal Injury in Mice
por: Yang, Xin-Jing, et al.
Publicado: (2018)

Tanshinone IIA: A Promising Natural Cardioprotective Agent
por: Shang, Qinghua, et al.
Publicado: (2012)

Neuron Regeneration and Proliferation Effects of Danshen and Tanshinone IIA
por: Shen, Jui-Lung, et al.
Publicado: (2011)

Evaluation of Tanshinone IIA Developmental Toxicity in Zebrafish Embryos
por: Wang, Tao, et al.
Publicado: (2017)

Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
por: Guo, Rui, et al.
Publicado: (2020)

Mitigating effect of tanshinone IIA on ventricular remodeling in rats with pressure overload-induced heart failure
por: Li, Xu, et al.
Publicado: (2019)

Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis
por: Zhu, Ji, et al.
Publicado: (2022)

The Attenuation of Traumatic Brain Injury via Inhibition of Oxidative Stress and Apoptosis by Tanshinone IIA
por: Huang, Yongpan, et al.
Publicado: (2020)

Donkey-derived anti-CDV IgG, as a passive immunotherapy agent, can effectively increase survival rates of the experimental CDV-infected dogs
por: Zhang, Jianlou, et al.
Publicado: (2021)

Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer
por: Liu, Zhigang, et al.
Publicado: (2019)

Possible mechanisms of treatment for spinal cord injury repair with tanshinone IIA
por: Jia, Zhiwei, et al.
Publicado: (2023)

Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis
por: Xu, Lianjie, et al.
Publicado: (2022)

Molecular cloning of chicken IL-7 and characterization of its antiviral activity against IBDV in vivo
por: Huo, Shanshan, et al.
Publicado: (2016)

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
por: Paramel Varghese, Geena, et al.
Publicado: (2016)

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
por: Zheng, Yanfang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ec7lik5t57jhe4uqe8mnspr84q